Endpoints News

Supreme Court tariff ruling lets stand Trump’s authority to target pharma

President Donald Trump lost one avenue to impose tariffs, but he still has the authority to place duties on pharmaceutical imports.

This report was first published by Endpoints News. To see the original version, click here

President Donald Trump lost one avenue to impose tariffs, but he still has the authority to place duties on pharmaceutical imports.

Nearly a year after Trump’s chaotic “Liberation Day” tariff rollout, the US Supreme Court ruled on Friday that Trump doesn’t have the authority to impose tariffs under the International Emergency Economic Powers Act (IEEPA). Trump had relied on the IEEPA to place broad, reciprocal tariffs on a list of countries including China (34%) and the EU (15%).

您已阅读26%(573字),剩余74%(1660字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归Endpoints News所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×